These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 2423808)

  • 1. Orthotopic Transplantation of Mouse Mammary Epithelial Cells.
    Faraldo MM; Glukhova MA; Deugnier MA
    Methods Mol Biol; 2022; 2471():123-139. PubMed ID: 35175594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suspension state regulates epithelial-to-mesenchymal transition and stemness of breast tumor cells.
    Lv Y; Zhang X; Chen L
    Biotechnol Lett; 2021 Mar; 43(3):561-578. PubMed ID: 33386502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advance in metabolism and target therapy in breast cancer stem cells.
    Gao X; Dong QZ
    World J Stem Cells; 2020 Nov; 12(11):1295-1306. PubMed ID: 33312399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer.
    Dwyer AR; Truong TH; Kerkvliet CP; Paul KV; Kabos P; Sartorius CA; Lange CA
    Br J Cancer; 2021 Jan; 124(1):217-227. PubMed ID: 33144693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-coding RNAs: the new central dogma of cancer biology.
    Saw PE; Xu X; Chen J; Song EW
    Sci China Life Sci; 2021 Jan; 64(1):22-50. PubMed ID: 32930921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways.
    Cruz-Lozano M; González-González A; Marchal JA; Muñoz-Muela E; Molina MP; Cara FE; Brown AM; García-Rivas G; Hernández-Brenes C; Lorente JA; Sanchez-Rovira P; Chang JC; Granados-Principal S
    Eur J Nutr; 2019 Dec; 58(8):3207-3219. PubMed ID: 30460610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoramin in the treatment of hypertension. A mini-review and update.
    Archibald JL; Turner P
    S Afr Med J; 1983 Feb; 63(9):307-9. PubMed ID: 6338605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indoramin in the hypertensive diabetic patient.
    Sood VP; Stannard M; Beastall G; Weir RJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S80-3. PubMed ID: 2423805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.
    Marshall AJ; Kettle MA; Barritt DW
    Br J Clin Pharmacol; 1980 Sep; 10(3):217-21. PubMed ID: 7437237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in angina pectoris with alpha adrenoceptor blockade.
    Collins P; Sheridan D
    Br Heart J; 1985 May; 53(5):488-92. PubMed ID: 2859870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-adrenoreceptor blockade with indoramin in hypertension.
    Gould BA; Mann S; Davies AB; Altman DG; Raftery EB
    J Cardiovasc Pharmacol; 1983; 5(3):343-8. PubMed ID: 6191130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.
    Holmes B; Sorkin EM
    Drugs; 1986 Jun; 31(6):467-99. PubMed ID: 3525084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoramin in the hypertensive patient with concomitant disease: clinical experience.
    Rosendorff C
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S93-7. PubMed ID: 2423808
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.